Selected References
- Asghar, et al.2024. LTRA use in pregnancy: a systematic review on their safety and association with congenital anomalies’. Journal of Regenerative Medicine, 13(2):1-8.
- Committee on Drugs. American Academy of Pediatrics. 2001. The transfer of drugs and other chemicals into human milk. Pediatrics, 108:776-789.
- Cossette B, et al. 2014. Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy. Annals of Allergy, Asthma & Immunology, 112(5):459–464.
- Eltonsy S, et al. 2011. Beta2-agonists use during pregnancy and the risk of congenital malformations. Birth Defects Research Part A: Clinical and Molecular Teratology, 91(11):937–947.
- Gregersen TL and Ulrik CS. 2013. Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better. J Asthma Allergy, 6:117–125.
- Lim A, et al. 2013. Asthma drugs in pregnancy and lactation. Australian Prescriber, 36(5):150–153.
- Lim A, et al. 2011. Systematic review of the safety of regular preventive asthma medications during pregnancy, Ann Pharmacother, 45(7-8):931-945.
- Namazy J, and Schatz M. 2018. Management of asthma during pregnancy: optimizing outcomes and minimizing risk. Seminars in Respiratory and Critical Care Medicine, 39(01): 029–035.
- National Asthma Education and Prevention Program. Working Group. 2004. Report on managing asthma during pregnancy: Recommendations for pharmacologic treatment. Update 2004. NIH publication NO.05-5236. Bethesda, MD: US Department of Health and Human Services; National Institutes of Health; National Heart, Lung and Blood Institute.
- Tamasi L, et al. 2005. The management of bronchial asthma during pregnancy – Hungarian experiences. Orv Hetil. 146(45):2035-2039.
- Wilton LV and Shakir SA. 2002. A postmarketing surveillance study of formoterol (Foradil). Its use in general practice in England. Drug Saf 25:213-223
